Interleukin-1 mediates Alzheimer and Lewy body pathologies
2006

Interleukin-1 and Neurodegenerative Diseases

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Griffin W Sue T, Liu Ling, Li Yuekui, Mrak Robert E, Barger Steven W

Primary Institution: University of Arkansas for Medical Sciences

Hypothesis

Does interleukin-1 mediate the pathologies associated with Alzheimer's and Lewy body diseases?

Conclusion

IL-1 drives the production of substrates necessary for the formation of major neuropathological changes characteristic of Alzheimer's and Lewy body diseases.

Supporting Evidence

  • IL-1β treatment of neurons increased sAPP release in a dose-dependent manner.
  • Microglial activation with sAPPα led to increased IL-1β secretion.
  • In vivo studies showed that IL-1β elevated α-synuclein mRNA levels in rat brains.

Takeaway

This study shows that a protein called IL-1 can make brain cells produce more harmful substances that are linked to diseases like Alzheimer's and Parkinson's.

Methodology

The study used rat primary cultures of microglia and cortical neurons, treated them with IL-1β, and analyzed mRNA for various neuropathological markers.

Participant Demographics

5 patients with combined AD/LBD, 2 males and 3 females, aged 68–85.

Statistical Information

P-Value

p<0.02

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-3-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication